Immunogenicity and Protective Efficacy of Virosome Based Vaccines Against Newcastle Disease

Overview

Journal Trop Anim Health Prod

Publisher Springer

Specialties Tropical Medicine
Veterinary Medicine

Date 2009 Sep 4

PMID 19728133

Citations 2

Authors

Rajinder Singh

Prem C Verma

Satparkash Singh

Affiliations

Soon will be listed here.

Abstract

Virosome based vaccines against Newcastle disease (ND) were prepared and evaluated for their immunogenicity and protective efficacy in chickens. Envelop of Newcastle disease virus (NDV) was solubilised with Triton X-100 to yield virosomes which were later on encapsulated in poly-lactide-co-glycolide (PLG) microspheres. The birds were immunized intranasally with virosomes or PLG microspheres encapsulated virosomes, and efficacy of these preparations was compared with commercial LaSota vaccine. The preparations protected the chickens against virulent virus challenge infection, however the microencapsulated virosome vaccine gave slightly lesser degree of protection than non encapsulated counterpart. The humoral and cell mediated immune response generated as well as the protection afforded by virosome preparations were found to be comparable with LaSota vaccine. The results substantiate the potential of virosome based vaccines to provide high level of immunity and protection against Newcastle disease.

Citing Articles

Development, Biological Characterization, and Immunological Evaluation of Virosome Vaccine against Newcastle Disease in Pakistan.

Rasool M, Mehmood A, Saqalein M, Nisar M, Almatroudi A, Khurshid M Biomed Res Int. 2021; 2021:8879277.

PMID: 33575353 PMC: 7864732. DOI: 10.1155/2021/8879277.

Formulation and delivery of vaccines: Ongoing challenges for animal management.

Sharma S, Hinds L J Pharm Bioallied Sci. 2012; 4(4):258-66.

PMID: 23248557 PMC: 3523519. DOI: 10.4103/0975-7406.103231.

References

Droual R, Bickford A, Charlton B, Kuney D . Investigation of problems associated with intramuscular breast injection of oil-adjuvanted killed vaccines in chickens. Avian Dis. 1990; 34(2):473-8. View

Eldridge J, Staas J, Meulbroek J, Tice T, Gilley R . Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies. Infect Immun. 1991; 59(9):2978-86. PMC: 258122. DOI: 10.1128/iai.59.9.2978-2986.1991. View

LoBue A, Thompson J, Lindesmith L, Johnston R, Baric R . Alphavirus-adjuvanted norovirus-like particle vaccines: heterologous, humoral, and mucosal immune responses protect against murine norovirus challenge. J Virol. 2009; 83(7):3212-27. PMC: 2655567. DOI: 10.1128/JVI.01650-08. View

Yamanaka M, Okabe T, Nakai M, Goto N . Local pathological reactions and immune response of chickens to ISA-70 and other adjuvants containing Newcastle disease virus antigen. Avian Dis. 1993; 37(2):459-66. View

Cannon M, Russell P . Secondary in vitro stimulation of specific cytotoxic cells to Newcastle disease virus in chickens. Avian Pathol. 1986; 15(4):731-40. DOI: 10.1080/03079458608436335. View

Kapczynski D, Tumpey T . Development of a virosome vaccine for Newcastle disease virus. Avian Dis. 2003; 47(3):578-87. DOI: 10.1637/6082. View

Chung Y, Ho M, Wu J, Chen W, Huang J, Chou S . Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine. 2008; 26(15):1855-62. DOI: 10.1016/j.vaccine.2008.01.058. View

Huckriede A, Bungener L, ter Veer W, Holtrop M, Daemen T, Palache A . Influenza virosomes: combining optimal presentation of hemagglutinin with immunopotentiating activity. Vaccine. 2003; 21(9-10):925-31. DOI: 10.1016/s0264-410x(02)00542-x. View

Rosas J, Hernandez R, Gascon A, Igartua M, Guzman F, Patarroyo M . Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66. Vaccine. 2001; 19(31):4445-51. DOI: 10.1016/s0264-410x(01)00192-x. View

10.

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

11.

Grimaldi S, Giuliani A, Ferroni L, Lisi A, Santoro N, Pozzi D . Engineered liposomes and virosomes for delivery of macromolecules. Res Virol. 1995; 146(4):289-93. DOI: 10.1016/0923-2516(96)80574-7. View

12.

Ramya R, Verma P, Chaturvedi V, Gupta P, Pandey K, Madhanmohan M . Poly(lactide-co-glycolide) microspheres: a potent oral delivery system to elicit systemic immune response against inactivated rabies virus. Vaccine. 2009; 27(15):2138-43. DOI: 10.1016/j.vaccine.2009.01.129. View

13.

Reynolds D, Maraqa A . Protective immunity against Newcastle disease: the role of cell-mediated immunity. Avian Dis. 2000; 44(1):145-54. View

14.

Hawkes R, Darbyshire J, Peters R, Mockett A, Cavanagh D . Presence of viral antigens and antibody in the trachea of chickens infected with avian infectious bronchitis virus. Avian Pathol. 1983; 12(3):331-40. DOI: 10.1080/03079458308436175. View

15.

Yusoff K, Tan W . Newcastle disease virus: macromolecules and opportunities. Avian Pathol. 2009; 30(5):439-55. DOI: 10.1080/03079450120078626. View

16.

Rao M, Bray M, Alving C, Jahrling P, Matyas G . Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells. J Virol. 2002; 76(18):9176-85. PMC: 136452. DOI: 10.1128/jvi.76.18.9176-9185.2002. View

17.

Bovier P . Epaxal: a virosomal vaccine to prevent hepatitis A infection. Expert Rev Vaccines. 2008; 7(8):1141-50. DOI: 10.1586/14760584.7.8.1141. View

18.

Kapczynski D, King D . Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic.... Vaccine. 2005; 23(26):3424-33. DOI: 10.1016/j.vaccine.2005.01.140. View

19.

Bagai S, Sarkar D . Reconstituted Sendai virus envelopes as biological carriers: dual role of F protein in binding and fusion with liver cells. Biochim Biophys Acta. 1993; 1152(1):15-25. DOI: 10.1016/0005-2736(93)90226-p. View

20.

Westbury H . Newcastle disease virus: an evolving pathogen?. Avian Pathol. 2009; 30(1):5-11. DOI: 10.1080/03079450020023131. View